American Oriental Bioengineering, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AOBI research report →
About the company
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications.
- CEO
- Shujun Liu
- IPO
- 2001
- Employees
- 3,719
- HQ
- Beijing, CN
Price Chart
- Market Cap
- $88
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -1.53
- Div Yield
- 0.00%
- Gross Margin
- 30.57%
- Op Margin
- -37.89%
- Net Margin
- -41.15%
- ROE
- -16.84%
- ROIC
- -13.88%
- Revenue
- $145.10M · -31.78%
- Net Income
- $-59,713,000 · 12.82%
- EPS
- $-781.24 · 13.37%
- Op Income
- $-54,972,000
- FCF YoY
- -264.46%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.20
- Avg Volume
- 575.644
Get TickerSpark's AI analysis on AOBI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AOBI coverage
Recent articles, reports, and earnings notes.
No research on AOBI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AOBI report →Similar companies
Peers in the same neighborhood.